These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 9383016

  • 41. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
    German DC, Nelson EL, Liang CL, Speciale SG, Sinton CM, Sonsalla PK.
    Neurodegeneration; 1996 Dec; 5(4):299-312. PubMed ID: 9117541
    [Abstract] [Full Text] [Related]

  • 42. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M, Mariani AP, Neff NH.
    Brain Res; 1989 Apr 10; 484(1-2):297-303. PubMed ID: 2565752
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice.
    Zou L, Xu J, Jankovic J, He Y, Appel SH, Le W.
    Neurosci Lett; 2000 Mar 10; 281(2-3):167-70. PubMed ID: 10704769
    [Abstract] [Full Text] [Related]

  • 45. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY, Park HJ, Ahn YH, Lee PH.
    J Neurochem; 2009 Nov 10; 111(4):1042-50. PubMed ID: 19765187
    [Abstract] [Full Text] [Related]

  • 46. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M.
    J Neurosci Res; 2007 Jun 10; 85(8):1752-61. PubMed ID: 17469135
    [Abstract] [Full Text] [Related]

  • 47. Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL/6 mice.
    Chen JY, Hsu PC, Hsu IL, Yeh GC.
    Neurosci Lett; 2001 Nov 13; 314(1-2):49-52. PubMed ID: 11698144
    [Abstract] [Full Text] [Related]

  • 48. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.
    Jiang H, Li LJ, Wang J, Xie JX.
    Exp Neurol; 2008 Aug 13; 212(2):532-7. PubMed ID: 18577498
    [Abstract] [Full Text] [Related]

  • 49. MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra.
    Zuddas A, Corsini GU, Schinelli S, Johannessen JN, di Porzio U, Kopin IJ.
    Brain Res; 1989 Oct 30; 501(1):1-10. PubMed ID: 2572305
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S.
    Neurodegeneration; 1995 Sep 30; 4(3):257-69. PubMed ID: 8581558
    [Abstract] [Full Text] [Related]

  • 52. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.
    Chadi G, Møller A, Rosén L, Janson AM, Agnati LA, Goldstein M, Ogren SO, Pettersson RF, Fuxe K.
    Exp Brain Res; 1993 Sep 30; 97(1):145-58. PubMed ID: 7907549
    [Abstract] [Full Text] [Related]

  • 53. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 30; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 54. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway.
    Morgan WW, Nelson JF.
    Brain Res; 2001 Dec 07; 921(1-2):115-21. PubMed ID: 11720717
    [Abstract] [Full Text] [Related]

  • 55. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice.
    Bolin LM, Strycharska-Orczyk I, Murray R, Langston JW, Di Monte D.
    J Neurochem; 2002 Oct 07; 83(1):167-75. PubMed ID: 12358740
    [Abstract] [Full Text] [Related]

  • 56. Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates.
    Swanson C, Emborg M.
    Neurol Res; 2014 Jul 07; 36(7):634-46. PubMed ID: 24620964
    [Abstract] [Full Text] [Related]

  • 57. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar 07; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 58. MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons.
    Gouty S, Brown JM, Rosenberger J, Cox BM.
    Neuroscience; 2010 Aug 11; 169(1):269-78. PubMed ID: 20417255
    [Abstract] [Full Text] [Related]

  • 59. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.
    Eur J Neurosci; 2009 Mar 11; 29(5):891-900. PubMed ID: 19245369
    [Abstract] [Full Text] [Related]

  • 60. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb 11; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.